Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
Ursa Brown-Glaberman, Alison T StopeckUniversity of Arizona Cancer Center, Tucson, AZ, USAAbstract: Skeletal-related events (SREs) including pain, fractures, and hypercalcemia are a major source of morbidity for cancer patients with bone metastases. The receptor activator of NF-κB liga...
Guardado en:
Autores principales: | Stopeck AT, Brown-Glaberman U |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3fb737279e1440e4b4da88af4ea2ee9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman U, et al.
Publicado: (2013) -
Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller CJ, et al.
Publicado: (2012) -
Giant-cell tumor of bone: treatment options and role of denosumab
por: Singh AS, et al.
Publicado: (2015) -
Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysis
por: Yuko Kanbayashi, et al.
Publicado: (2021) -
Denosumab: an investigational drug for the management of postmenopausal osteoporosis
por: E Michael Lewiecki
Publicado: (2008)